BMS-986231
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BMS-986231, covering 2017-05-31 to 2021-01-26. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic [Phase 2]